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  We describe 2 cases of malignant fibrous histiocytomas 
(MFHs) that spontaneously developed in young pet dogs. 
To classify these tumors, we applied a panel of antibodies 
(vimentin, desmin,  α-SMA, and ED1) and Azan staining 
for collagen. The MFHs were most consistent with osteoclast- 
like giant and inflammatory cell types. The first case had 
positive  staining  for  ED1  and  vimentin,  and  given  the 
osteoclast-like giant cells, calcification sites accompanying 
peripheral  giant  cell  infiltrates.  The  latter  case,  the 
inflammatory cell type, exhibited a storiform-pleomorphic 
variant of neoplastic cells, including an ossifying matrix. 
MFHs  are  among  the  most  highly  aggressive  tumors 
occurring in soft tissue sarcomas in elderly dogs; however, 
MFHs have been poorly studied from a diagnostic point of 
view. Herein, we describe the histologic and immunohistologic 
features of MFHs in detail, thus classifying the subtypes of 
these tumors.
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  Malignant fibrous histiocytomas (MFHs) are mesenchymal 
tumors frequently occurring in skeletal muscles and 
cutaneous regions in elderly humans; the visceral form is 
most common in young immunodepressed humans [6,7,10]. 
Based on histologic and immunohistologic studies, most of 
the tumors have been shown to originate from fibroblasts 
and/or myofibroblasts, presumably from undifferentiated 
mesenchymal cells [2,3,5]. MFHs have been diagnostic 
dilemmas because of the histologic variation from plexiform 
fibrohistiocytic to infiltrative subcutaneous fibroblast-like 
spindle cell types [7,10]. 
  The neoplasm is characterized by a mixture of neoplastic 
fibroblasts, histiocytes, and multi-nucleated giant cells that 
interlace in tight bundles [8]. Large giant cells that resemble 
osteoclasts are generally present [1]. The primary tumor 
cells are pleomorphic, vary in appearance from fusiform-to- 
round, and have a nucleus with one or two prominent and 
irregular nucleoli [8]. Extracellular amorphous eosinophilic 
material may be prominent and likely represents reactive 
collagen production by the neoplastic cells [8]. 
  The osteoclast-like giant cell type of MFH is rare. The 
characteristic features of the osteoclast-like giant cell type 
have not been described in detail in domestic animals. Thus, 
we studied the histopathologic features of osteoclast-like 
giant cell type MFH with calcifications in a young healthy 
dog and compared of the findings to another case of 
inflammatory MFH.
  A two-month old female Shih-tzu was brought to a local 
veterinary clinic with a raised subcutaneous mass in the left 
dorsal region. Because of the rapid growth of the mass, the 
veterinarian performed a surgical excision. The mass was 
2.5 cm in diameter and had well-defined boundaries without 
involving the surrounding tissues. The tumor was circumscribed 
with an incomplete capsule, was firm and gritty, and 
included focal calcifications of dense portions. 
  The second case involved a 6-year old male Pointer. The 
dog had a history of a mass at the same site 3 years earlier 
with a red-to-brown blood-filled nodule, approximately 2 
cm in diameter, in the left ultimate costa. The clinical 
examination revealed that the nodule extended into the 
muscle layer. 
  Biopsies from each dog were submitted to Kyungpook 
National University for pathologic evaluation. The masses 
were fixed in 10% neutral-buffered formalin, and paraffin- 
embedded tissues were sectioned at 4 μm and stained with 
hematoxylin and eosin (H&E) and Azan for collagen 
activity in the neoplastic cells. Immunohistochemical 
evaluation was performed using commercially available 
antibodies. The source and dilution of the primary 
antibodies were as follows: anti-vimentin (clone V9, 1：
100; DAKO, USA), anti-desmin (clone D33, 1:100; 
DAKO), anti-α-smooth muscle actin (α-SMA: clone 1A4, 
1:800; Sigma, St. Louis, MO, USA), and anti-monocytes/ 
macrophages antibody (clone ED-1, 1：100; Chemicon, 
USA). Histologically, the two masses extended from the 
subcutaneous tissue into the dermis. The first mass was 170    Sun Hee Do et al.
Fig. 1. Malignant fibrous histiocytoma (MFH), subtype osteoclast-like giant cell type (A-E). Osteoclast-like giant cells (arrow head) 
resembling normal osteoclast are scattered throughout the lesion, especially around the calcification sites. In addition to these features,
peripheral giant cells (arrow) appeared (A). Immunostaining for vimentin, desmin, α-SMA, and ED1, respectively (B-E). Tumor cells
were positive for vimentin (B), and negative for α-SMA (D) and ED1 (E). Note the strong positive for desmin of smooth muscle cells
of blood vessels vs. negative staining of tumor cells (C). Osteoclast-like giant cells showed positive for ED1 (E). Inflammatory cell type
of MFH (F-H). This type of MHF was characterized by infiltration of various inflammatory cells (F) and ossifying matrix (G). Note the
bone matrix surrounding the neoplastic fibroblasts (H). A, F and G: H&E stain, B, C, D and E: ABC method counterstained with 
hematoxylin, H: Azan stain. A-E: ×66, F and G: ×132, H: ×33.
composed of spindle-shaped neoplastic cells with a storiform 
pattern intermixed with blood vessels and a few inflammatory 
cells. Giant cells were scattered throughout the lesion, 
especially around the calcification site, and resembled 
normal osteoclasts (Fig. 1A). In addition, peripheral giant 
cells were seen in association with epitheloid cells, which 
is a common feature in giant cell type MFH. Multinucleated 
giant cells engulfed calcifying material at the site of 
calcification. Areas of necrosis and hemorrhage were seen 
in the adjacent fat and muscle tissue. The tumor cells were 
positive for vimentin (Fig. 1B), and negative for desmin 
(Fig. 1C) and α-SMA (Fig. 1D). The osteoclast-like giant 
cells, the majority of giant cells in this case, were positive 
for ED1 on immunohistochemical staining (Fig. 1E). The 
histologic appearance of this lesion was a salient feature of 
the osteoclast-like giant cell type of MFH. The animal was 
very young compared to most animals in which such tumors 
have been reported.
  The tumor consisted of neoplastic histiocytes, hyperplastic 
fibroblasts, and an ossifying matrix, including spindle cell 
areas showing an occasional storiform pattern in the second 
case. The undifferentiated sarcoma was diagnosed as an 
inflammatory cell type of MFH because of mixed cellularity 
with a heavy infiltration of lymphocytes, plasma cells, and 
neutrophils (Fig. 1F). An ossifying matrix was also detected 
as the result of continuous and reactive hyperplasia of 
fibroblasts (Fig. 1G). At the center of the tumor, areas of 
osteocentral fibrous histiocytomas, characterized by bone 
matrix formation, were present (Fig. 1H). The neoplasm also 
included neovascularization, necrosis of affected muscle 
cells, and involvement of the surrounding tissue. 
  MFH is one of the most common soft tissue sarcomas in 
elderly humans and animals in which the cells have 
morphologic features of both fibroblasts and histiocytes. 
Generally, the storiform-pleomorphic type of MFH exhibits 
a cartwheel (storiform) pattern of fibroblast-like cells and 
histiocytoid cells. Inflammatory-type tumors showed bizzare 
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lymphocytes, plasma cells, eosinophils, and neutrophils. 
Tumors of the giant type had multi-nucleated giant cells, 
spindle cells, and mononuclear histiocytic cells. Human 
MFHs have been classified into 5 subtypes based on the 
pattern and predominance of the cell types: storiform- 
pleomorphic, inflammatory, giant cell, myxoid, and 
angiomatoid, but only the first three types have been 
reported in non-human animals [2,5]. 
    The origin of histiocyte-like cells in MFH remains 
controversial. In some reports, three possible cells have been 
proposed: 1) facultative histiocytic cells that are able to 
differentiate into fibroblasts, 2) fibroblasts, and 3) primitive 
mesenchymal cells that are able to differentiate into 
fibroblasts and histiocytes [1,4]. In most cases of MFH, 
immunohistochemical studies have not supported the 
hypothesis that these tumor cells are derived from true 
histiocytes [8,9]. Several other studies have suggested that 
the immunohistologic heterogenity of MFH tumor cells 
indicate that these tumors are indeed from a primitive cell 
type or are the end result of “differentiation” of several 
different types of sarcomas [4,8]. The undifferentiated 
mesenchymal cell-origin tumors in which giant cells are 
usually present have also been described as fascial sarcomas, 
epithelioid sarcomas, malignant histiocytomas, reticulum 
cell sarcomas, and giant cell tumors [8].
  The specimens of the first case included the osteoclast- like 
giant cell type of MFH, a rare case in non-human animals, 
with large numbers of osteoclast-like giant cells and 
multi-nucleated giant cells engulfing calcified materials. 
This tumor had immunoreactivity for vimentin. However, 
the tumor showed no immunoreactivity for desmin and α- 
SMA. The osteoclast-like giant cell type of MFH rarely 
occurs in young animals. In addition, the second case 
showed typical findings of the inflammatory cell type of 
MFH with an ossifying matrix resulting from continuous 
fibroblast reactive hyperplasia and bone matrix surrounding 
neoplastic fibroblasts in the central region of the lesion.
  The current report may be important in identifying MFHs 
based on histologic and immunohistologic findings and 
classifying the subtypes of these tumors that have atypical 
features occurring in pet dogs.
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